On December 17th 2021 Hyris presented its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which addressed strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2.
With the SARS-CoV-2 pandemic still causing further disruption of public security and companies’ workflows worldwide, Hyris keeps supporting medical professionals and researchers testing the presence of SARS-CoV-2 into human beings. A fresh, new demo immed
Hyris developed a rapid T-Cell test, which leverages the power of the Hyris SystemTM to track patients' immunity levels to SARS-CoV-2 for research and global clinical use. The new test has been brought to market after having inked an exclusive licensing agreement with Singapore Duke-NUS Medical School.
Hyris CE-IVD marked test for COVID human diagnostic "bKIT Virus Finder COVID-19" is at the core of the signature Article "Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection", from the Department of Laboratory Medicine of the National Institute for The Study and Treatment of Cancer IRCCS "Fondazione G Pascale" (IRCCS Pascale), of Naples (Italy)
Hyris bKIT Virus Finder Covid-19 is the first commercially available, rapid COVID-19 medical device approved by Health Canada for point-of-care human testing. Exclusively distributed by Songbird Life Science, it is fast becoming the preferred choice of industry leaders across Canada.
Hyris bCUBE based test kit is the only authorised medical device approved for human tests in Point of Care currently commercially available in Canada. Hyris Ltd. now focuses on supporting Canada in fully facing the new virus escalation.
Hyris Ltd first ranking for the Regione Lombardia COVID-19 Research fund with the project: COVES – Sviluppo e validazione di una metodica rapida per la rilevazione di SARS-CoV-2 su superfici ambientali
Toronto based Purity-IQ Inc., has partnered exclusively with Hyris, a leader in Artificial Intelligence applications for advanced diagnostics with offices in London, Milan and Singapore, to support their business expansion in the Americas.